- Home
- NUWE vs TCBP Comparison
NUWE vs TCBP Comparison
Compare NUWE & TCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- TCBP
- Stock Information
- Founded
- NUWE 1999
- TCBP 2013
- Country
- NUWE United States
- TCBP United Kingdom
- Employees
- NUWE N/A
- TCBP N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NUWE Health Care
- TCBP Health Care
- Exchange
- NUWE Nasdaq
- TCBP Nasdaq
- Market Cap
- NUWE 5.1M
- TCBP 5.0M
- IPO Year
- NUWE N/A
- TCBP 2022
- Fundamental
- Price
- NUWE $1.21
- TCBP $0.38
- Analyst Decision
- NUWE Strong Buy
- TCBP Strong Buy
- Analyst Count
- NUWE 1
- TCBP 1
- Target Price
- NUWE $17.00
- TCBP $2.40
- AVG Volume (30 Days)
- NUWE 316.1K
- TCBP 3.1M
- Earning Date
- NUWE 03-04-2025
- TCBP 11-25-2024
- Dividend Yield
- NUWE N/A
- TCBP N/A
- EPS Growth
- NUWE N/A
- TCBP N/A
- EPS
- NUWE N/A
- TCBP N/A
- Revenue
- NUWE $8,969,000.00
- TCBP N/A
- Revenue This Year
- NUWE $2.18
- TCBP N/A
- Revenue Next Year
- NUWE $25.75
- TCBP N/A
- P/E Ratio
- NUWE N/A
- TCBP N/A
- Revenue Growth
- NUWE 3.66
- TCBP N/A
- 52 Week Low
- NUWE $0.92
- TCBP $0.37
- 52 Week High
- NUWE $27.65
- TCBP $32.70
- Technical
- Relative Strength Index (RSI)
- NUWE 53.66
- TCBP 30.77
- Support Level
- NUWE $0.99
- TCBP $0.37
- Resistance Level
- NUWE $1.26
- TCBP $0.47
- Average True Range (ATR)
- NUWE 0.08
- TCBP 0.10
- MACD
- NUWE 0.02
- TCBP 0.01
- Stochastic Oscillator
- NUWE 81.48
- TCBP 2.65
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.